Sudinnova invests in EyeBrain

Other investors in the round include Octalfa and CM-CIC Capital Innovation. They joined previous investors CapDecisif Management and G1JIDF, which invested €1.2m in the company in 2009.

The company will use the capital to build a sales force and further support its R&D programmes.

Company
EyeBrain develops non-invasive brain function markers for neurological and psychiatric diseases. The company is based in Paris where it was set up in 2008. It curently employs 12 people. EyeBrain generates revenue from selling its tracker device – eye motricity testing (eye tracking) is paid for by the French social security system.

Advisers
Equity – MAGS (Legal); AVVENS (Financial due diligence); L&C (IP due diligence).
Company – Joffe & Associates (Legal); SECOM (Financial due diligence).

 

 

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Healthcare
• France